151606-30-3 Usage
Description
DEPHOSTATIN is a chemical compound that contains the active ingredient Alendronate Sodium, a bisphosphonate medication used to treat and prevent bone disorders such as osteoporosis and Paget's disease. It functions by decelerating the breakdown of bone cells, thereby enhancing bone density and strength. DEPHOSTATIN is typically administered orally once a week, and its effectiveness in reducing fracture risk and improving bone health has been demonstrated in individuals with specific bone conditions.
Uses
Used in Pharmaceutical Industry:
DEPHOSTATIN is used as a bone-strengthening agent for the treatment and prevention of osteoporosis and Paget's disease. It is utilized to increase bone density and reduce the risk of fractures in affected individuals.
Used in Healthcare:
DEPHOSTATIN is used as a medication to improve bone health by slowing down the bone cell breakdown process, which is crucial for patients with conditions that compromise bone strength and integrity.
Check Digit Verification of cas no
The CAS Registry Mumber 151606-30-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,6,0 and 6 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 151606-30:
(8*1)+(7*5)+(6*1)+(5*6)+(4*0)+(3*6)+(2*3)+(1*0)=103
103 % 10 = 3
So 151606-30-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H8N2O3/c1-9(8-12)6-4-5(10)2-3-7(6)11/h2-4,8,12H,1H3
151606-30-3Relevant articles and documents
Total Synthesis of Dephostatin, a Novel Protein Tyrosine Phosphatase Inhibitor
Watanabe, Takumi,Takeuchi, Tomio,Otsuka, Masami,Umezawa, Kazuo
, p. 437 - 438 (2007/10/02)
The first synthesis of dephostatin, conducted by use of a silyl protective group removable with HF-NaF buffer without damaging the labile N-nitrosamino group, is described.
